Depending on the presence of m6A modifications, the translation of the target gene mRNA can be promoted by METTL3, thus leading to malignant cancer development, including AML [92], ovarian cancer [93], and colorectal cancer (CRC) [94]. Here, METTL3 is linked to cancer.